Search Results

ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening (ICARE-LCS)

• Authors : VA Oncology and Precision Medicine; VA Tobacco Use Treatment National Program Office; VA National Center for Lung Cancer Screening

• Source: ICARE-LCS QUERI Partnered Evaluation Initiative: Integrating Comprehensive Tobacco Treatment to Enhance Lung Cancer Screening (PEC 24-239)

Record details

Precision Lung Cancer Survivorship Care Intervention (KYLEADSII)

• Authors : University of Louisville; G02 for Lung Cancer; National Cancer Institute (NCI) ...

• Source: Precision Lung Cancer Survivorship Care Intervention: A Randomized Controlled Trial Serving Rural Survivors and Communities

Record details

Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

• Authors : Lung Cancer Research Foundation

• Source: Increasing Lung Cancer Screening Uptake Among Emergency Department Patients

Record details

Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer (BLCIO)

• Authors : Peter Shields, Principal Investigator

• Source: Beating Lung Cancer in Ohio (BLCIO) ProtocolPark KR, Shields PG, Myers JV, Reisinger SA, Andersen BL. Depression and Inflammation

Record details

A Clinical Study for the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung Cancer Transformed From Non-Small Cell Lung Cancer Following EGFR TKI Therapy

• Source: An Open-Label, Single-Arm Phase I/II Clinical Study to Evaluate the Efficacy and Safety of BL0020 Injection in Patients With Small Cell Lung

Record details

Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors

• Source: Tissue Procurement and Natural History Study of Patients With Non-Small Cell Lung Cancer, Small Cell Lung

Record details

Testing the Impact of an Anti-Cancer Drug, Atezolizumab, After Surgery to Prevent Early Stage Non-small Cell Lung Cancer From Returning, AASI-NSCLC Trial

• Source: Evaluating Adjuvant Atezolizumab or Atezolizumab and Hyaluronidase-TQJS to Prevent Recurrence in Stage I Non-Small Cell Lung Cancer

Record details

Bispecific T-Cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated Extensive-Stage Small Cell Lung Cancer and Extrapulmonary Neuroendocrine Cancer

• Source: A Phase I/II Study to Assess the Safety and Antitumor Activity of Bispecific T-cell Engager Tarlatamab and TROP2 Targeted Antibody Drug Conjugate Sacituzumab Govitecan in Previously Treated

Record details

Testing the SurVaxM Vaccine for Lung Cancer Prevention

• Source: Evaluating the Feasibility of a Survivin Peptide Vaccine (SurVaxM) as an Interception Agent in Patients at High Risk for Lung Cancer

Record details

Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial

• Source: Randomized Phase III Trial INcorporating Pathologic Complete ReSponse in Participants With Early StaGe Non Small Cell Lung Cancer to

Record details